In these trials, 63% were White, 6% were Black or African American and 27% were Asian
Semaglutide Semaglutide is a medication that supports weight loss and blood sugar management by reducing appetite and promoting feelings of fullness
The study, part of a multicenter, randomized, double-blind trial conducted at 42 institutions in the United States, quantitatively analyzed changes in total fat mass using dual-energy X-ray absorptiometry, or DXA, to track shifts in the ratio between fat and muscle
Twenty-five units from a 1 mg/mL vial is 0.25 mg
Microdosing allows for: Lower overall medication exposure
Ask about alternatives (e.g., tirzepatide, liraglutide, phentermine/topiramate) and how they fit your goals and health history